Agilent Completes Acquisition of BioTek Instruments
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations: investor.agilent.com
Builds on Multi-Year Growth Strategy in Critical Cell Analysis Technology SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation.The BioTek acquisition expands Agilent’s growing presence and expertise in cell analysis and strengthens the company’s position in the large and growing immuno-oncology and immunotherapy areas. The combined portfolio will allow Agilent to deliver a range of unique cell analysis workflows to provide customers the ability to obtain deeper, more reliable insights across a variety of cell analysis applications. This combination expands the company’s presence in biopharma, academia and research, as customers seek to understand complex cellular environments and interactions.“We’re extremely pleased to add BioTek’s tremendously talented employees and industry leading tech
[Read more]
| Impact snapshot | Event time: | A | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
A alerts
A alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent Announced as My Green Lab's First 'Transformative Level' Sponsor and First Sponsor of the My Green Lab Certification ProgramPR Newswire
- Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaBusiness Wire
- Remote Jobs on the Rise: Virtual Vocations Unveils Top Employer Partners in Q3 ReportPR Web
- Agilent Technologies, Inc. (<a href="https://www.marketbeat.com/stocks/NYSE/A/price-target/">NYSE: A</a>) had its price target lowered by analysts at Cowen Inc from $200.00 to $180.00. They now have an "outperform" rating on the stock.MarketBeat
- Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast CancerBusiness Wire
- More
A
SEC Filings
- 9/23/21 - Form 4
- 9/23/21 - Form 3
- 9/23/21 - Form 8-K
- A's page on the SEC website
- More